Skip to content Skip to sidebar Skip to footer
leukemia

Development of novel phospholipase A2 inhibitors as an innovative targeted therapy for cancer, in particular leukemia

A recent report entitled «Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2α for targeted cancer therapy», published in the prestigious journal Nature Communications, describes the development of novel inhibitors of the enzyme phospholipase A2 as a targeted therapy for cancer, in…

Read More

UoA © 2025. All Rights Reserved

Skip to content
GR